Vedanta Biosciences
Developer of orally delivered defined bacterial consortia designed to treat inflammatory and infectious diseases. The company's platform includes libraries of bacteria derived from the human microbiom...
Valuation
$0
Share Price
N/A
Total Raised
$366.1M
Last Round
N/A